[Circadian variations in the onset of acute myocardial infarction]
M Trappolini1, S Matteoli, M C Borgia
1Policlinico Umberto I, Dipartimento di Scienze Cliniche, Università degli Studi La Sapienza, Rome, Italy.
Insights
Acute myocardial infarction (AMI) shows a morning peak incidence, particularly in men and smokers. This circadian pattern is absent in diabetics and hypertensives, with higher mortality for nighttime AMIs.
Area of Science:
- Cardiology
- Chronobiology
- Epidemiology
Context:
- Circadian patterns in acute myocardial infarction (AMI) onset are established, with a known morning peak.
- Variations in these rhythms across patient subgroups are suspected but not fully elucidated.
Purpose:
- To investigate whether the circadian incidence of AMI differs based on sex, age, cardiovascular risk factors, prior ischemic events, AMI location, and short-term outcomes.
- To identify specific patient subgroups exhibiting distinct circadian patterns in AMI onset.
Summary:
- A significant peak incidence of AMI occurred between 6:01 AM and 12:00 PM (32.4%).
- This morning peak was observed in patients aged 65+, men, smokers, and those with/without hypercholesterolemia.
- Circadian rhythmicity was absent in diabetics, hypertensives, and those with previous cardiovascular events. Inferior AMI showed a morning peak, unlike anterior or non-Q wave AMI.
- Mortality was higher for AMIs with onset during nighttime hours.
Impact:
- Provides insights into chronobiological factors influencing AMI, particularly morning triggers.
- Highlights the need for tailored preventive strategies and treatment approaches considering patient-specific circadian rhythms.
- Informs clinical practice regarding the timing of interventions and risk management for acute myocardial infarction.
Background:
Several studies have observed a circadian pattern in the onset of acute myocardial infarction (AMI), with a peak incidence in the morning hours. It has been suggested that different circadian rhythms may exist in various subgroups of patients.
Methods:
This study sought to determine whether the circadian incidence of AMI varied by sex, age, cardiovascular risk factors, previous history of ischemic accidents, the site of AMI, and the short-term outcome. These possibilities were examined in a population of 597 consecutive patients with AMI, admitted to the coronary care unit. 548 patients have been included in the study, 442 men (80.6%) and 106 women (19.4 %); mean age 64.5 years.
Results:
A peak incidence of AMI was found between 06.01 a.m. and 12.00 a.m. (32.4%; p<0.0002). This peak was present in patients 65 years old (33.2%; p<0.005), in men (32.5%; p<0.0002) but not in women, in smokers (32.1%; p<0.0005) and in those that did not smoke (33.0%; p<0.04), in patients with hypercholesterolemia (34.9%; p<0.006 ) and without hypercholesterolemia (31.1%; p<0.03). A circadian rhythm was absent in diabetics, hypertensives and in patients with a history of previous cardiovascular events. Regarding the site of AMI, inferior AMI showed an increased incidence between 06.01 a.m. and 12.00 a.m. (36.2%; p<0.002), while the circadian distribution of anterior AMI, as well as non-Q wave AMI, did not show this incidence. Finally, higher mortality was reported in patients with an AMI onset at night (22.3%).
Conclusions:
These results give further clues in understanding the external and inner factors acting in the morning hours as triggers for AMI.
More Related Videos
09:59A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
08:51Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
Published on: September 20, 2024
Related Concept Videos
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
